The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

por Machleidt, Anna, Buchholz, Stefan, Diermeier-Daucher, Simone, Zeman, Florian, Ortmann, Olaf, Brockhoff, Gero
Publicado 2013

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer

por Sassen, Andrea, Diermeier-Daucher, Simone, Sieben, Manuela, Ortmann, Olaf, Hofstaedter, Ferdinand, Schwarz, Stephan, Brockhoff, Gero
Publicado 2009

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

por Wege, Anja Kathrin, Chittka, Dominik, Buchholz, Stefan, Klinkhammer-Schalke, Monika, Diermeier-Daucher, Simone, Zeman, Florian, Ortmann, Olaf, Brockhoff, Gero
Publicado 2018

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))

por GAUMANN, ANDREAS K.A., DREXLER, HANNES C.A., LANG, SVEN A., STOELTZING, OLIVER, DIERMEIER-DAUCHER, SIMONE, BUCHDUNGER, ELISABETH, WOOD, JEANETTE, BOLD, GUIDO, BREIER, GEORG
Publicado 2014